Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Dexcom (DXCM) Other Gross PP&E Adjustments (2016 - 2025)

Dexcom (DXCM) has disclosed Other Gross PP&E Adjustments for 16 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 20.06% to $2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 20.06% increase, with the full-year FY2025 number at $2.3 billion, up 20.06% from a year prior.
  • Other Gross PP&E Adjustments was $2.3 billion for Q4 2025 at Dexcom, up from $2.2 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.3 billion in Q4 2025 to a low of $663.1 million in Q1 2021.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 76.96% in 2021, then rose 14.2% in 2024.
  • Dexcom's Other Gross PP&E Adjustments stood at $931.9 million in 2021, then skyrocketed by 41.86% to $1.3 billion in 2022, then grew by 15.29% to $1.5 billion in 2023, then grew by 26.82% to $1.9 billion in 2024, then grew by 20.06% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Other Gross PP&E Adjustments are $2.3 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.2 billion (Q2 2025).